DiseaseID 5247
戒断症状
disease
NCI2016_02D:A substance-specific organic brain syndrome that follows the discontinuation of administration or use, or reduction in intake of an addictive substance, e.g. opioids, barbiturates and alcohol; amphetamines or
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Disease: 1Symptom: 12Target: 12Links: 24
Arranging relationship network...
Record Fields
Scalar fields from the final disease record.
- Disease Id
- 5247
- Core Entity Id
- 61717
- Source Entity Count
- 1
- Preferred Name
- Withdrawal Symptoms
- Name Cn
- 戒断症状
- Name Pinyin
- Jie Duan Zheng Zhuang
- Name En
- Withdrawal Symptoms
- Name Latin
- Bilingual Status
- complete
- Disease Type
- disease
- Umls Disease Type
- Mental or Behavioral Dysfunction
- Disgenet Type
- disease
- Mesh Class
- Mental Disorders; Chemically-Induced Disorders
- Do Class
- Hpo Class
- Mesh Class Name
- Chemically-Induced Disorders; Mental Disorders
- Hpo Class Name
- Do Class Name
- Disease Definition
- NCI2016_02D:A substance-specific organic brain syndrome that follows the discontinuation of administration or use, or reduction in intake of an addictive substance, e.g. opioids, barbiturates and alcohol; amphetamines or similarly acting sympathomimetics; cocaine; nicotine; sedatives, hypnotics, or anxiolytics. Syndrome manifests with diverse, often painful physical and psychological symptoms, which include but not limited to intense drug craving, anxiety, depression, insomnia, nausea, perspiration, body aches, tremors, hallucinations, and convulsions.|MSH2017_2016_08_12:Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
- Version
- v2
- Suppressed
- No
Names
Preferred names, aliases, and source labels retained in the final schema.
Name
Withdrawal Symptoms
Role
preferred
Name
Substance Withdrawal Syndrome
Role
preferred
Name
Drug Withdrawal Symptoms
Role
preferred
Cross References
Trusted external identifiers retained for this final record.
Herb
HBDIS002870HBDIS003388HBDIS003443
Me Sh
D013375
Umls
C0038587
Sym Map
SMDE13717
Dis Ge Net
C0038587C0086189C0087169
Umls Sty
T048T184
Me Sh Class
C25F03
Tcmbank Disease
24888296903259
Itcmdb Generated
ITX-DISEASE-A233C360D427
Attributes
Merged source attributes and domain-specific metadata.
Version
v2
Suppress
0
Disease Type
diseasephenotype
Umls Disease Type
Mental or Behavioral DysfunctionSign or Symptom
Disease Definition
NCI2016_02D:A substance-specific organic brain syndrome that follows the discontinuation of administration or use, or reduction in intake of an addictive substance, e.g. opioids, barbiturates and alcohol; amphetamines or similarly acting sympathomimetics; cocaine; nicotine; sedatives, hypnotics, or anxiolytics. Syndrome manifests with diverse, often painful physical and psychological symptoms, which include but not limited to intense drug craving, anxiety, depression, insomnia, nausea, perspiration, body aches, tremors, hallucinations, and convulsions.|MSH2017_2016_08_12:Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
Me Sh Disease Class
Mental Disorders; Chemically-Induced Disorders
Dis Ge Net Disease Type
diseasephenotype
Disease Class Name Me Sh
Chemically-Induced Disorders; Mental Disorders
Umls Semantic Type Name
Mental or Behavioral DysfunctionSign or Symptom